יוקריאס 50/850 מ"ג

দেশ: ইস্রায়েল

ভাষা: হিব্রু

সূত্র: Ministry of Health

সক্রিয় উপাদান:

METFORMIN HYDROCHLORIDE 850 MG; VILDAGLIPTIN 50 MG

থেকে পাওয়া:

NOVARTIS PHARMA SERVICES AG

এটিসি কোড:

A10BA02

ফার্মাসিউটিকাল ফর্ম:

FILM COATED TABLETS

প্রশাসন রুট:

PER OS

Manufactured by:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

থেরাপিউটিক গ্রুপ:

METFORMIN

থেরাপিউটিক ইঙ্গিত:

Eucreas is indicated in the treatment of type 2 diabetes mellitus:• Eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

অনুমোদন তারিখ:

2010-07-01